Toll Free: 1-888-928-9744
Published: Jun, 2014 | Pages:
32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Quest PharmaTech Inc. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Quest PharmaTech Inc. - Product Pipeline Review - 2014', provides an overview of the Quest PharmaTech Inc.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Quest PharmaTech Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Quest PharmaTech Inc. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Quest PharmaTech Inc.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Quest PharmaTech Inc.'s pipeline products Reasons to buy - Evaluate Quest PharmaTech Inc.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Quest PharmaTech Inc. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Quest PharmaTech Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Quest PharmaTech Inc. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Quest PharmaTech Inc. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Quest PharmaTech Inc. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Quest PharmaTech Inc. Snapshot 5 Quest PharmaTech Inc. Overview 5 Key Information 5 Key Facts 5 Quest PharmaTech Inc. - Research and Development Overview 6 Key Therapeutic Areas 6 Quest PharmaTech Inc. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Pipeline Products - Partnered Products 10 Partnered Products/Combination Treatment Modalities 11 Quest PharmaTech Inc. - Pipeline Products Glance 12 Quest PharmaTech Inc. - Clinical Stage Pipeline Products 12 Phase II Products/Combination Treatment Modalities 12 Phase I Products/Combination Treatment Modalities 13 Quest PharmaTech Inc. - Early Stage Pipeline Products 14 Preclinical Products/Combination Treatment Modalities 14 Quest PharmaTech Inc. - Drug Profiles 15 oregovomab 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 AR-20.5 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 SL-052 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 Monoclonal Antibody to Inhibit PSA for Prostate Cancer 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Monoclonal Antibody To Target MUC1 for Oncology 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Quest PharmaTech Inc. - Pipeline Analysis 22 Quest PharmaTech Inc. - Pipeline Products by Target 22 Quest PharmaTech Inc. - Pipeline Products by Route of Administration 23 Quest PharmaTech Inc. - Pipeline Products by Molecule Type 24 Quest PharmaTech Inc. - Pipeline Products by Mechanism of Action 25 Quest PharmaTech Inc. - Recent Pipeline Updates 26 Quest PharmaTech Inc. - Dormant Projects 28 Quest PharmaTech Inc. - Discontinued Pipeline Products 29 Discontinued Pipeline Product Profiles 29 ACP-2127 29 oregovomab 29 Quest PharmaTech Inc. - Locations And Subsidiaries 30 Head Office 30 Appendix 31 Methodology 31 Coverage 31 Secondary Research 31 Primary Research 31 Expert Panel Validation 31 Contact Us 32 Disclaimer 32
List of Tables Quest PharmaTech Inc., Key Information 5 Quest PharmaTech Inc., Key Facts 5 Quest PharmaTech Inc. - Pipeline by Indication, 2014 7 Quest PharmaTech Inc. - Pipeline by Stage of Development, 2014 8 Quest PharmaTech Inc. - Monotherapy Products in Pipeline, 2014 9 Quest PharmaTech Inc. - Partnered Products in Pipeline, 2014 10 Quest PharmaTech Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11 Quest PharmaTech Inc. - Phase II, 2014 12 Quest PharmaTech Inc. - Phase I, 2014 13 Quest PharmaTech Inc. - Preclinical, 2014 14 Quest PharmaTech Inc. - Pipeline by Target, 2014 22 Quest PharmaTech Inc. - Pipeline by Route of Administration, 2014 23 Quest PharmaTech Inc. - Pipeline by Molecule Type, 2014 24 Quest PharmaTech Inc. - Pipeline Products by Mechanism of Action, 2014 25 Quest PharmaTech Inc. - Recent Pipeline Updates, 2014 26 Quest PharmaTech Inc. - Dormant Developmental Projects,2014 28 Quest PharmaTech Inc. - Discontinued Pipeline Products, 2014 29
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.